3-Quinuclidinone Hydrochloride

We are 3-Quinuclidinone Hydrochloride CAS:1193-65-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 3-Quinuclidinone Hydrochloride
CAS.NO:  1193-65-3
Synonyms:
1-azabicyclo[2.2.2]octan-3-one,hydrochloride
3-Quinuclidinone hydrochloride
3-Quinuclidone hydrochloride
3-Quinuclidnone hydrochloride
Quinuclidin-3-one hydrochloride
1-Azabicyclo[2.2.2]octan-3-one hydrochloride

Molecular Formula: C7H12ClNO
Molecular Weight:   161.62900

Physical and Chemical Properties:
Density: /
Boiling point: 204.9ºCat 760 mmHg
Melting point: >300 °C (dec.)(lit.)
Flash point: 78.1ºC
Refractive index: /

Specification:
Appearance: White powder
Purity:≥99.0%
Loss on drying:≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store at 2 ºC -8 ºC.Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
3-quinuclidinone hydrochloride (1193-65-3) is an intermediate for the production of solifenacin and aminoquinine, as well as a drug for the treatment of acute and delayed nausea and vomiting caused by moderate to severe emetic chemotherapy drugs Raw materials for Palonosetron.Intermediates of Solifenacin succinate CAS:242478-38-2.

Related News: Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed.Dialilamina CAS:124-02-7 Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed.5-cloro-3-metilpiridin-2-amina CAS:20712-16-7 In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation.D-metionina CAS:348-67-4 Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.